Julie E. Kurzrok
Frommer Lawrence & Haug LLP
Author, FDA Lawyers Blog, www.fdalawyersblog.com
Julie Kurzrok's practice focuses primarily on intellectual property litigation. Her litigation experience is mainly in pharmaceutical patent litigation arising under the Hatch-Waxman Amendments to the Federal Food, Drug & Cosmetic Act. Prior to attending law school, she worked for Schering Plough Research Institute in the field of preclinical reproductive toxicology.
Frommer Lawrence & Haug LLP [Associate] 2008- Present
Ms. Kurzrok's experience involves all phases of litigation, including fact and expert discovery, motions, and trial practice. Her experience also includes preparing witnesses for depositions and taking depositions.
Schering Plough Research Institute [Assistant Scientist II] 2002-2005
At Schering Plough, Ms. Kurzrok performed pre-clinical drug testing in reproductive toxicology. In this role, she complied with Standard Operating Procedures and Good Laboratory Practices.
B.S. Biological Sciences, Binghamtom University, 2000
M.S. Biology, Rutgers University, 2005
J.D., Rutgers University School of Law at Camden, 2008
Recent Representative Publications
Julie E. Kurzrok and Stephen J. Lieb, "Unigene Labs., Inc. v. Apotex, Inc.: Non-Obvious Function of Chemical Component May Lead Away from Pharmaceutical Formulation Patent Claims" in Federal Circuit Law Update Vol. 14 Issue 11, the Business Suit, 2011, available at
Julie E. Kurzrok and Stephen J. Lieb, "Daiichi Sankyo Co., Ltd. v. Matrix Labs., Ltd.: In the Search for the Perfect Lead Compound, Looks Aren't Everything" in Federal Circuit Law Update Vol. 13 Issue 11, the Business Suit, 2010, available at
Julie Salka and Stephen J. Lieb, "Laches and the Statute of Limitations in Copyright Infringement" in Defending Intellectual Property Claims Vol. II, DRI Defense Library Series, 2007